Orforglipron
Foundayo; LY3502970; OWL-833
Also known as Foundayo; LY3502970; OWL-833
2 listings from 2 vendors, normalised to one honest price per milligram.
Prices last collected November 21, 2026. Prices change often - check the vendor's site before ordering.
Choose a size to compare vendor prices.
Foundayo; LY3502970; OWL-833
Orforglipron is an oral once-daily non-peptide small-molecule glucagon-like peptide-1 receptor agonist. In 2026 it was approved by the FDA under the brand Foundayo for chronic weight management in adults with obesity or with overweight and a weight-related condition, used with a reduced-calorie diet and increased physical activity. It has also been studied in type 2 diabetes.
It is a non-peptide molecule that activates the GLP-1 receptor, promoting glucose-dependent insulin secretion and reducing appetite.
Weight management; obesity; type 2 diabetes
29 to 49 hours
Beginner
Approved - large human trials
Phase 3
Risk of thyroid C-cell tumors; contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Disclosure. Some vendors above are Peptul partners and pay us a commission when you buy through our link. Rows are ordered by: Peptul partners first, then what is in stock, then single vials before multi-vial packs, then price per milligram. Paying us moves a vendor up this order and changes nothing else - not their trust tier, COA badge, Peptul Score or reviews, which come from evidence and are worked out the same way for everyone. Available discount codes are shown beside the prices above. Discounted prices require the displayed code where indicated.
For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.